Effect of preoperative antibiotic use on the implant success rate: a retrospective cohort study of cefixime and ornidazole in China
Authors:
Open Access
- 26 September 2025
- journal article
- research article
- Published by Springer Nature in BMC Oral Health
- Vol. 25 (1) , 1-9
Abstract
This study aims to enhance the current clinical understanding of prophylactic antibiotic treatment in China before implant surgeries, and improve the experience and adherence of patients who undergo implant procedures. Patients eligible for inclusion in the past six years were divided into two groups of 500 patients each. Patients in the medication group received one 500 mg cefixime tablet and one 500 mg ornidazole tablet 0.5 hours before implantation. Patients in the non-medicated group did not receive any medicine. Patients were evaluated at two follow-ups: 7–14 days and 3–6 months after implant surgeries. The primary outcome was implant failure, which was characterized as implant detachment or complete loss during follow-ups, implant mobility (clinical mobility >1 mm) detected by surgeons when manually tightening abutments at the second follow-up (3–6 months after surgeries), or complications requiring clinical intervention occurred, including peri-implant bone resorption exceeding acceptable levels. Secondary outcomes were postoperative infection and adverse events. We statistically analyzed study outcomes using the Pearson Chi-square test, Fisher's exact test, and a multiple logistic regression model to evaluate differences between the two groups. P values less than 0.05 or 95% confidence intervals of relative risk or odds ratio values excluding one were considered statistically significant. We noted implant failures (medication group: four patients, 0.8% and non-medicated group: three patients, 0.6%) and postoperative infections (medication group: 23 patients, 4.6% and non-medicated group: 25 patients, 5.0%) were no statistically significant difference between the two groups. However, adverse events showed a statistically significant increase in the medication group (medication group: 111 patients, 22.2% and non-medicated group: 21 patients, 4.2%), including nausea, vomiting, hypersomnia, dizziness, and diarrhea. There was a statistically non-significant increase in fever in the non-medicated group. No statistically significant evidence existed in preventing postoperative infection between the two groups across smoking status, age, implant system, number of implants (1, 2–3, and ≥4), sinus elevation surgery, implant placement, and guided bone regeneration surgery. Antibiotic prophylaxis using ornidazole in conjunction with cefixime in implant surgery may not have clinical benefits but significantly increases adverse events. Therefore, the necessity of prophylactic antibiotic use in healthy patients before implant surgeries needs to be reconsidered.Keywords
Funding Information
- Undergraduate Research and Innovation Fund Program of Hunan University of Chinese Medicine (2024BKS034)
- General Project of University and College Joint Fund of Hunan University of Chinese Medicine (2024XYLH298)
- Changsha Natural Science Foundation project (kq2502309)
This publication has 42 references indexed in Scilit:
- Infectious Diseases Society of America 2024 Guidance on the Treatment of Antimicrobial-Resistant Gram-Negative InfectionsClinical Infectious Diseases, 2024
- The effect of preoperative clindamycin in reducing early oral implant failure: a randomised placebo-controlled clinical trialClinical Oral Investigations, 2022
- The impact of a quality improvement initiative to reduce denture loss in an acute hospitalBritish Dental Journal, 2022
- Management of systemic risk factors ahead of dental implant therapy: A beard well lathered is half shavedJournal of Leukocyte Biology, 2021
- The Benefits and Harms of Antibiotic Prophylaxis for Urinary Tract Infection in Older AdultsClinical Infectious Diseases, 2021
- Using Artificial Intelligence in Infection PreventionCurrent Treatment Options in Infectious Diseases, 2020
- Prevalence of antimicrobial resistance genes in Bacteroides spp. and Prevotella spp. Dutch clinical isolatesClinical Microbiology and Infection, 2019
- How to measure quantitative antibiotic use in order to support antimicrobial stewardship in acute care hospitals: a retrospective observational studyEuropean Journal of Clinical Microbiology & Infectious Diseases, 2018
- Implementing an Antibiotic Stewardship Program: Guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of AmericaClinical Infectious Diseases, 2016
- Ornidazole: Comprehensive Profile2003